AI Insight
Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults, characterized by microscopic extensions into healthy brain tissue that make complete surgical removal nearly impossible. The cancer creates an immunosuppressive microenvironment that enables it to evade immune system detection and resist standard therapeutic interventions. Space-grown organoids of this tumor type are being developed to advance research into more effective treatment strategies.
Why it matters
Improved glioblastoma models, including those grown in microgravity conditions, could lead to better understanding of the tumor's immune evasion mechanisms and potentially help develop more effective therapies for a cancer that currently has very limited treatment options and poor patient outcomes.
Understand the Science
Glioblastoma (GBM) is the most common malignant primary brain tumor in adults and is one of the most aggressive and deadly forms of cancer. It is difficult for surgeons to fully remove GBM because it often has microscopic “tentacles” that extend from the tumor into healthy brain tissue. GBM is also hard to treat because it creates an immunosuppressive microenvironment that helps the cancer evade immune attack and resist therapy.
Source: Space-grown glioblastoma organoids could help advance brain cancer treatments